Table 2.

Unadjusted and adjusted breast cancer mortality hazard ratios

	Unadjusted Hazard Ratios	p-value	Adjusted Hazard Ratios*	p-value
Age at diagnosis
< 50 years	1 (Ref)		1 (Ref)
≥ 50 years	0.71 (0.52–0.95)	0.024	0.97 (0.71–1.32)	0.829
Linear Trend	0.99 (0.98–1.00)	0.131	1.01 (0.99–1.02)	0.483
Molecular Subtype
Luminal A	1 (Ref)		1 (Ref)
Luminal B	1.24 (0.78–1.98)	0.365	1.09 (0.68–1.75)	0.716
HER2-enriched	2.38 (1.49–3.80)	< 0.001	1.85 (1.15–2.98)	0.011
;Basal like	2.07 (1.29–3.33)	0.003	1.93 (1.20–3.10)	0.007
HIV status
;HIV negative	1 (Ref)		1 (Ref)
;HIV positive	2.08 (1.55–2.80)	< 0.001	2.14 (1.58–2.90)	< 0.001
Stage at diagnosis
Early stage (1 and 2)	1 (Ref)		1 (Ref)
Advanced stage (3 and 4)	3.59 (2.56–5.02)	< 0.001	3.65 (2.60–5.12)	< 0.001
Risk of recurrence
Low	1 (Ref)		1 (Ref)
Intermediate	0.78 (0.30–2.03)	0.615	1.00 (0.38–2.62)	0.993
High	2.66 (1.36–5.19)	0.004	2.18 (1.11–4.28)	0.023
Linear Trend	1.01 (1.01–1.02)	0.002	1.01 (1.00–1.02)	0.049

*Adjusted for age, stage, HIV status